The Valley Desk

NCT01924793 · Interventional trial

An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection

Overall registry status Completed

Phase 2

Conditions Parainfluenza

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov